The Business of Bud: 2017 Cannabis Industry Update (SOLD OUT)
Tell a Friend About This EventTell a Friend

When: Thursday, February 23rd
From 3:00pm until 6:30pm
Where: Golden Gate University
536 Mission St
San Francisco, California  94105
United States

Online registration is closed.
« Go to Upcoming Event List  

The Business of Bud: 2017 Cannabis Industry Update


Pro Cannabis votes across the country enacted "legal" access for over 50% of US adults.  What spurred this change?  Is it just about getting high or is there something bigger?  Will it spawn the next Budweiser, Jack Daniels or Genentech?  Sifting through the American Medical Journal or High Times, it could be all of the above. Major banks and investment companies are quietly (and sometimes not so quietly) researching the gold rush for MJ aka the Green Rush.  There could be great opportunities and most certainly great pitfalls. 

Join CFA Society San Francisco on February 23rd for an educational event to discuss the topic with recognized leaders on cannabis market research, investment, and regulation. 



Tim Morland, Director of Legislative and Regulatory Affairs, State Board of Equalization, State of California. 
Tim has extensive knowledge of the California legislative process. Tim was hired by the State Board of Equalization Member Fiona Ma in January of 2015 as the Assistant Legislative and Regulatory Affairs Director. In November of 2015, he was promoted to Director of Legislative and Regulatory Affairs. He currently serves on the Cannabis Compliance project within the State Board of Equalization. Prior to joining Board Member Fiona Ma's team, Tim served in the Assembly Chief Clerk's Office, the Assembly Daily File Clerk and the Reading Clerk for the California State Assembly. He graduated from California State University Sacramento with high honors in 2008 (Phi Kappa Phi)with a degree in Government

Troy Dayton, Arcview investment
Arcview is a leading source of investment deal flow in the cannabis industry and active in market research and analysis.Troy is frequently quoted in the NYTimes, Washington Post, Fortune, CNN, NPR, Fox, Bloomberg and CNBC.  Arcview's group of 600+ high net worth investors have allocated  more than $91 million into 135 cannabis related companies. Troy cofounded cannabis business accelerator Canopy and cannabis insurance company Cannasure. Troy is a board member for the Marijuana Policy Project and was formerly their top fundraiser and lead liaison to the legal cannabis industry. He is a founding board member of the National Cannabis Industry Association and co-founder of Students for Sensible Drug Policy, which is now on over 300 campuses. He was recently named by Fortune Magazine as one of the top 7 most powerful people in the cannabis industry.

Morgan Paxhia, Co-Founder, Poseidon Asset Management
Poseidon Asset Management is a hedge fund focused on the cannabis industry. Since 2013 Poseidon has invested in 30+ cannabis related companies across technology, data analytics, agtech, real estate, media, biotech, cultivation and industrial hemp processing. Morgan has developed investment methodology in a highly inefficient emerging industry and created frameworks for analysis based on sub-sector, company stage, capital participation and other metrics to diversify risk for investors.  Morgan has been quoted in the WSJ, Barrons, Fortune, CNBC and many other publications.  Earlier in his career he was in asset management with UBS. Morgan earned his Bachelor of Science in Applied Mathematics from the University of Rhode Island.



Members: $25
Non-Members: $40


Thursday, February 23rd, 2017
3:00 PM until 6:30 PM



Golden Gate University
536 Mission St,
San Francisco, CA 94105


Cancellation Policy
Please contact with at least 24 hours notice to receive a full refund.



This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.